Literature DB >> 23681605

Increased noradrenaline levels in the rostral pons can be reversed by M1 antagonist in a rat model of post-traumatic stress disorder.

Berna Terzioğlu1, Melisa Kaleli, Banu Aydın, Sema Ketenci, Hülya Cabadak, M Zafer Gören.   

Abstract

The dysregulation of hypothalamic-pituitary-adrenal axis and noradrenergic, serotonergic and glutamatergic systems are thought to be involved in the pathophysiology of post-traumatic stress disorder. The effect of selective M1 muscarinic receptor antagonist, pirenzepine on anxiety indices was investigated by using elevated plus maze, following exposure to trauma reminder. Upon receiving the approval of ethics committee, Sprague-Dawley rats were exposed to dirty cat litter (trauma) for 10 min and 1 week later, the rats confronted to a trauma reminder (clean litter). The rats also received intraperitoneal pirenzepine (1 or 2 mg/kg/day) or saline for 8 days. Noradrenaline (NA) concentration in the rostral pons was analyzed by HPLC with electrochemical detection. The anxiety indices of the rats subjected to the trauma reminder were increased when compared to control rats (p < 0.05). Pirenzepine treatment in traumatized rats displayed similar anxiety indices of non-traumatized rats treated with physiological saline. Although freezing time was prolonged with pirenzepine in traumatized groups the change was not found statistically significant. The NA level was 1.5 ± 0.1 pg/mg in non-traumatized rats and increased to 2.4 ± 0.2 pg/mg in traumatized rats. Bonferroni post hoc test revealed that the NA content of the rostral pons of the traumatized rats treated with physiological saline was significantly higher than the content of other groups (p < 0.01). We conclude that NA content in the rostral pons increases in respect to confrontation to a trauma reminder which can be reversed by M1 antagonist pirenzepine indicating the roles of M1 receptors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681605     DOI: 10.1007/s11064-013-1076-2

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  53 in total

Review 1.  Norepinephrine dysfunction in depression.

Authors:  A Anand; D S Charney
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

2.  Nucleus accumbens muscarinic receptors in the control of behavioral depression: antidepressant-like effects of local M1 antagonist in the Porsolt swim test.

Authors:  D T Chau; P Rada; R A Kosloff; J L Taylor; B G Hoebel
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 3.  The contribution of an animal model toward uncovering biological risk factors for PTSD.

Authors:  Hagit Cohen; Michael A Matar; Gal Richter-Levin; Joseph Zohar
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

4.  Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies.

Authors:  A I Levey; C A Kitt; W F Simonds; D L Price; M R Brann
Journal:  J Neurosci       Date:  1991-10       Impact factor: 6.167

5.  Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity.

Authors:  A L Curtis; S M Lechner; L A Pavcovich; R J Valentino
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

6.  Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

Authors:  Maura L Furey; Ashish Khanna; Elana M Hoffman; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

7.  Acute stress facilitates long-lasting changes in cholinergic gene expression.

Authors:  D Kaufer; A Friedman; S Seidman; H Soreq
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

8.  Catecholamine depletion in mice upon reexposure to stress: mediation of the escape deficits produced by inescapable shock.

Authors:  H Anisman; L S Sklar
Journal:  J Comp Physiol Psychol       Date:  1979-08

9.  Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice.

Authors:  E T Tzavara; F P Bymaster; C C Felder; M Wade; J Gomeza; J Wess; D L McKinzie; G G Nomikos
Journal:  Mol Psychiatry       Date:  2003-07       Impact factor: 15.992

10.  Cortical/hippocampal monoamines, HPA-axis changes and aversive behavior following stress and restress in an animal model of post-traumatic stress disorder.

Authors:  Brian H Harvey; Linda Brand; Zakkiyya Jeeva; Dan J Stein
Journal:  Physiol Behav       Date:  2006-03-06
View more
  7 in total

1.  M3 muscarinic receptor in the ventral medial prefrontal cortex modulating the expression of contextual fear conditioning in rats.

Authors:  A G Fedoce; N C Ferreira-Junior; D G Reis; F M A Corrêa; L B M Resstel
Journal:  Psychopharmacology (Berl)       Date:  2015-10-31       Impact factor: 4.530

2.  Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.

Authors:  Marissa A Smail; Jessica L Soles; Tracy E Karwoski; Robert T Rubin; Michael E Rhodes
Journal:  Brain Res Bull       Date:  2017-11-07       Impact factor: 4.077

3.  Does Beta-Blockade Reduce the Risk of Depression in Patients with Isolated Severe Extracranial Injuries?

Authors:  Rebecka Ahl; Galinos Barmparas; Louis Riddez; Eric J Ley; Göran Wallin; Olle Ljungqvist; Shahin Mohseni
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

4.  The Neurochemical Effects of Prazosin Treatment on Fear Circuitry in a Rat Traumatic Stress Model.

Authors:  Sema Ketenci; Nazife Gökçe Acet; Gökçe Elif Sarıdoğan; Banu Aydın; Hülya Cabadak; Mehmet Zafer Gören
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

5.  Behavioral effects of Bj-PRO-7a, a proline-rich oligopeptide from Bothrops jararaca venom.

Authors:  L C Turones; K R da Cruz; G Camargo-Silva; L L Reis-Silva; D Graziani; P M Ferreira; P M Galdino; G R Pedrino; R Santos; E A Costa; D Ianzer; C H Xavier
Journal:  Braz J Med Biol Res       Date:  2019-11-07       Impact factor: 2.590

6.  The behavioral and neurochemical effects of methylprednisolone or metyrapone in a post-traumatic stress disorder rat model.

Authors:  Ayse Melek Tanriverdi; Banu Aydin; Berna Terzioglu Bebitoglu; Hulya Cabadak; M Zafer Goren
Journal:  North Clin Istanb       Date:  2019-07-17

7.  Valeriana jatamansi Jones ex Roxb. Against Post-Traumatic Stress Disorder, Network Pharmacological Analysis, and In Vivo Evaluation.

Authors:  Xue Yang; Jian-You Guo; Ya-Ni Jiang; Meng-Meng Liu; Qiu-Yu Li; Jia-Yuan Li; Xiao-Jia Wei; Guo-Hui Wan; Jin-Li Shi
Journal:  Front Pharmacol       Date:  2021-12-07       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.